Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects

Clinical trial NCT02516618 · COMPLETED

Trial details

NCT number: NCT02516618
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2015-07-01
Primary completion: 2016-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.